BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21905620)

  • 1. [Detection of circulating tumor cells from peripheral blood in patients with transitional cell carcinoma--pilot study. Comparison with the standard histopathological staging].
    Nagy V; Rosocha J; Zidzik J; Bohus P
    Klin Onkol; 2011; 24(4):287-92. PubMed ID: 21905620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients.
    Yuasa T; Yoshiki T; Isono T; Tanaka T; Hayashida H; Okada Y
    Int J Urol; 1999 Jun; 6(6):286-92. PubMed ID: 10404304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients.
    Gazzaniga P; Gandini O; Giuliani L; Magnanti M; Gradilone A; Silvestri I; Gianni W; Gallucci M; Frati L; Aglianò AM
    Clin Cancer Res; 2001 Mar; 7(3):577-83. PubMed ID: 11297251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
    Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
    Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
    Okegawa T; Kinjo M; Nutahara K; Higashihara E
    J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder.
    Li SM; Zhang ZT; Chan S; McLenan O; Dixon C; Taneja S; Lepor H; Sun TT; Wu XR
    J Urol; 1999 Sep; 162(3 Pt 1):931-5. PubMed ID: 10458411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
    Güdemann CJ; Weitz J; Kienle P; Lacroix J; Wiesel MJ; Soder M; Benner A; Staehler G; Doeberitz MV
    J Urol; 2000 Aug; 164(2):532-6. PubMed ID: 10893639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
    Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
    Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
    Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
    World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
    Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
    J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
    Ribal MJ; Mengual L; Marín M; Algaba F; Ars E; Fernández PL; Oliva R; Villavicencio H; Alcaraz A
    Anticancer Res; 2006; 26(1A):411-9. PubMed ID: 16475726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and expression of uroplakins in transitional cell carcinoma.
    Yuasa T; Yoshiki T; Isono T; Tanaka T; Okada Y
    Adv Exp Med Biol; 2003; 539(Pt A):33-46. PubMed ID: 15088894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
    Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
    Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract.
    Hyrsl L; Zavada J; Zavadova Z; Kawaciuk I; Vesely S; Skapa P
    Neoplasma; 2009; 56(4):298-302. PubMed ID: 19473055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients.
    Retz M; Lehmann J; Röder C; Weichert-Jacobsen K; Loch T; Romahn E; Lühl C; Kalthoff H; Stöckle M
    Eur Urol; 2001 May; 39(5):507-15; discussion 516-7. PubMed ID: 11464030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
    Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of circulating urothelial cancer cells in the blood using the CellSearch System.
    Naoe M; Ogawa Y; Morita J; Omori K; Takeshita K; Shichijyo T; Okumura T; Igarashi A; Yanaihara A; Iwamoto S; Fukagai T; Miyazaki A; Yoshida H
    Cancer; 2007 Apr; 109(7):1439-45. PubMed ID: 17326057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating MUC7-positive cells by reverse transcription-polymerase chain reaction in bladder cancer patients.
    Kinjo M; Okegawa T; Horie S; Nutahara K; Higashihara E
    Int J Urol; 2004 Jan; 11(1):38-43. PubMed ID: 14678183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of rare circulating tumor cells by folate receptor α ligand-targeted PCR in bladder transitional cell carcinoma and its potential diagnostic significance.
    Qi F; Liu Y; Zhao R; Zou X; Zhang L; Li J; Wang Y; Li F; Zou X; Xia Y; Wang X; Xing L; Li C; Lu J; Tang J; Zhou F; Liu C; Gui Y; Cai Z; Sun X
    Tumour Biol; 2014 Jul; 35(7):7217-23. PubMed ID: 24771263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.